Salivary Oxytocin Levels in Children with and Without Autism: Group Similarities and Subgroup Variability

dc.contributor.author Yılmazer, E.
dc.contributor.author Çınaroğlu, M.
dc.contributor.author Köse, S.
dc.contributor.author Ülker, S.V.
dc.contributor.author Tarlacı, S.
dc.date.accessioned 2026-01-30T14:56:58Z
dc.date.available 2026-01-30T14:56:58Z
dc.date.issued 2025
dc.description.abstract Background: Oxytocin (OXT), a neuropeptide involved in social bonding, has been proposed as a potential biomarker for autism spectrum disorder (ASD) due to its role in modulating social behaviors. However, prior studies on peripheral OXT levels in individuals with ASD have yielded inconsistent results, partly due to methodological and developmental variability. This study aimed to compare baseline salivary OXT concentrations between children with ASD and typically developing controls. Methods: In this cross-sectional, case–control study, salivary OXT levels were measured in 35 children aged 6–9 years (18 with ASD, 17 controls) using a standardized ELISA protocol. Samples were collected under controlled conditions and analyzed in duplicate. Between-group differences in raw and log-transformed OXT levels were examined using t-tests. Subgroup analyses were conducted by sex, and correlations with autism symptom severity (Aberrant Behavior Checklist, ABC) were assessed within the ASD group. Results: Children with ASD showed higher mean salivary OXT levels than controls (21.5 pg/mL vs. 14.0 pg/mL), but the difference was not statistically significant (Welch’s t = −1.79, p = 0.088). Log transformation of OXT values confirmed the non-significant group difference (t = 1.68, p = 0.102). Female participants with ASD had significantly higher OXT than female controls (p = 0.048), while no difference was observed among males. OXT levels did not significantly correlate with autism severity (r = −0.04, p = 0.88). Conclusions: Baseline salivary OXT levels do not significantly differ between children with and without ASD and do not correlate with behavioral symptom severity. However, elevated OXT in females with ASD warrants cautious interpretation and further investigation. Salivary OXT may not be a reliable standalone diagnostic biomarker but could have exploratory value for understanding sex-specific neurobiological profiles in autism. © 2025 by the authors. en_US
dc.identifier.doi 10.3390/jcm14196760
dc.identifier.issn 2077-0383
dc.identifier.scopus 2-s2.0-105019191617
dc.identifier.uri https://doi.org/10.3390/jcm14196760
dc.identifier.uri https://acikerisim2.beykoz.edu.tr/handle/123456789/318
dc.language.iso en en_US
dc.publisher Multidisciplinary Digital Publishing Institute (MDPI) en_US
dc.relation.ispartof Journal of Clinical Medicine en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Autism Spectrum Disorder en_US
dc.subject Biomarker en_US
dc.subject Children en_US
dc.subject ELISA en_US
dc.subject Oxytocin en_US
dc.subject Saliva en_US
dc.title Salivary Oxytocin Levels in Children with and Without Autism: Group Similarities and Subgroup Variability en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 59212605300
gdc.author.scopusid 59173534400
gdc.author.scopusid 60147857300
gdc.author.scopusid 58798566800
gdc.author.scopusid 6603217281
gdc.description.department Beykoz University en_US
gdc.description.departmenttemp [Yılmazer] Eda, Department of Psychology, Beykoz Üniversitesi, Istanbul, Turkey; [Çınaroğlu] Metin, Department of Psychology, Istanbul Nisantasi University, Istanbul, Turkey; [Köse] Salih, Department of Psychology, Üsküdar Üniversitesi, Istanbul, Turkey; [Ülker] Selami Varol, Department of Psychology, Üsküdar Üniversitesi, Istanbul, Turkey; [Tarlacı] Sultan, Department of Neurology, Üsküdar Üniversitesi, Istanbul, Turkey en_US
gdc.description.issue 19 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality N/A
gdc.description.volume 14 en_US
gdc.description.wosquality N/A
gdc.index.type Scopus

Files